Arcus Biosciences, Inc.
NEWS
Arcus Biosciences and Genentech, a Roche company, are partnering on two clinical trials for colorectal and pancreatic cancer. They will evaluate Arcus’s AB928 in various combinations.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.
Companies strengthen their leadership teams and boards of directors with this week’s slate of Movers & Shakers.
Biopharma companies make changes to their C-suite leadership teams, with hires at uBiome, Enzyre, Sobi, Amylyx, Mission Therapeutics, and more.
Taiho Ventures, the corporate venture capital arm of Taiho Pharmaceutical, has pumped up its venture capital pool from $50 million to $300 million. It also indicates it plans to accelerate its “open innovation” through the investments.
The Loncar Cancer Immunotherapy Index has reduced the number of immunotherapy-focused companies from 30 to 25 and also swapped out a number of stocks as part of an effort to strengthen the index’s liquidity profile and ensure the holdings hold equal weight.
Sage Therapeutics has been on a roll with good news lately.
Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing.
JOBS
IN THE PRESS